Your browser is no longer supported. Please, upgrade your browser.
Settings
AAPL Apple Inc. daily Stock Chart
AAPL [NASD]
Apple Inc.
IndexDJIA S&P500 P/E33.81 EPS (ttm)3.29 Insider Own0.07% Shs Outstand17.25B Perf Week-4.85%
Market Cap1913.54B Forward P/E28.65 EPS next Y3.88 Insider Trans-6.71% Shs Float17.09B Perf Month-2.53%
Income58.42B PEG2.68 EPS next Q0.71 Inst Own62.10% Short Float0.52% Perf Quarter15.60%
Sales273.86B P/S6.99 EPS this Y-2.60% Inst Trans-0.20% Short Ratio0.52 Perf Half Y51.40%
Book/sh4.19 P/B26.54 EPS next Y19.67% ROA17.70% Target Price121.43 Perf Year82.83%
Cash/sh5.41 P/C20.57 EPS next 5Y12.60% ROE70.70% 52W Range53.15 - 137.98 Perf YTD51.47%
Dividend0.82 P/FCF33.19 EPS past 5Y13.00% ROI26.90% 52W High-19.41% Beta1.33
Dividend %0.74% Quick Ratio1.40 Sales past 5Y7.30% Gross Margin38.20% 52W Low109.21% ATR3.74
Employees137000 Current Ratio1.50 Sales Q/Q10.90% Oper. Margin24.50% RSI (14)39.05 Volatility2.91% 2.83%
OptionableYes Debt/Eq1.57 EPS Q/Q18.40% Profit Margin21.30% Rel Volume0.84 Prev Close116.60
ShortableYes LT Debt/Eq1.31 EarningsOct 29 AMC Payout23.60% Avg Volume170.74M Price111.20
Recom2.20 SMA20-5.02% SMA50-5.33% SMA20023.27% Volume142,742,375 Change-4.63%
Oct-26-20Resumed Atlantic Equities Overweight $150
Sep-21-20Reiterated Citigroup Buy $112.50 → $125
Sep-17-20Reiterated Jefferies Buy $116.25 → $135
Sep-16-20Reiterated Needham Buy $112.50 → $140
Sep-14-20Reiterated Oppenheimer Outperform $105 → $125
Sep-01-20Reiterated JP Morgan Overweight $115 → $150
Sep-01-20Reiterated Cowen Outperform $530 → $133
Aug-31-20Reiterated Monness Crespi & Hardt Buy $117.50 → $144
Aug-26-20Reiterated Wedbush Outperform $515 → $600
Aug-25-20Reiterated Cowen Outperform $470 → $530
Aug-24-20Reiterated Morgan Stanley Overweight $431 → $520
Aug-10-20Reiterated Wedbush Outperform $475 → $515
Aug-05-20Downgrade BofA Securities Buy → Neutral $420 → $470
Jul-31-20Reiterated Wedbush Outperform $450 → $475
Jul-31-20Reiterated UBS Buy $400 → $425
Jul-31-20Reiterated RBC Capital Mkts Outperform $390 → $445
Jul-31-20Reiterated Oppenheimer Outperform $320 → $420
Jul-31-20Reiterated Morgan Stanley Overweight $419 → $431
Jul-31-20Reiterated Monness Crespi & Hardt Buy $370 → $470
Jul-31-20Reiterated Credit Suisse Neutral $340 → $380
Oct-28-20 11:19PM  
10:15PM  
10:04PM  
09:19PM  
08:49PM  
08:08PM  
06:07PM  
05:43PM  
05:00PM  
04:21PM  
04:03PM  
03:26PM  
02:51PM  
02:48PM  
01:36PM  
01:34PM  
01:31PM  
01:14PM  
12:38PM  
12:36PM  
12:21PM  
11:34AM  
11:20AM  
10:20AM  
10:03AM  
10:00AM  
09:42AM  
09:36AM  
09:20AM  
09:07AM  
08:50AM  
08:30AM  
07:44AM  
06:30AM  
06:19AM  
05:10AM  
04:15AM  
04:08AM  
03:00AM  
Oct-27-20 09:53PM  
09:03PM  
08:26PM  
07:22PM  
06:10PM  
05:45PM  
05:09PM  
05:02PM  
04:38PM  
04:25PM  
04:01PM  
03:22PM  
02:15PM  
01:28PM  
12:45PM  
12:20PM  
12:09PM  
12:02PM  
10:45AM  
10:17AM  
10:12AM  
10:11AM  
10:02AM  
10:00AM  
09:59AM  
08:00AM  
08:00AM  
08:00AM  
07:45AM  
07:01AM  
07:00AM  
06:46AM  
06:04AM  
03:55AM  
12:30AM  
Oct-26-20 10:24PM  
08:21PM  
07:36PM  
06:47PM  
06:13PM  
06:00PM  
05:47PM  
05:04PM  
04:56PM  
04:54PM  
04:20PM  
04:18PM  
04:15PM  
03:41PM  
02:53PM  
02:47PM  
01:57PM  
01:45PM  
01:43PM  
12:49PM  
12:46PM  
12:30PM  
12:18PM  
10:43AM  
10:23AM  
10:22AM  
Apple Inc. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide. It also sells various related services. The company offers iPhone, a line of smartphones; Mac, a line of personal computers; iPad, a line of multi-purpose tablets; and wearables, home, and accessories comprising AirPods, Apple TV, Apple Watch, Beats products, HomePod, iPod touch, and other Apple-branded and third-party accessories. It also provides digital content stores and streaming services; AppleCare support services; and iCloud, a cloud service, which stores music, photos, contacts, calendars, mail, documents, and others. In addition, the company offers various service, such as Apple Arcade, a game subscription service; Apple Card, a co-branded credit card; Apple News+, a subscription news and magazine service; and Apple Pay, a cashless payment service, as well as licenses its intellectual property, and provides other related services. The company serves consumers, and small and mid-sized businesses; and the education, enterprise, and government markets. It sells and delivers third-party applications for its products through the App Store, Mac App Store, and Watch App Store. The company also sells its products through its retail and online stores, and direct sales force; and third-party cellular network carriers, wholesalers, retailers, and resellers. Apple Inc. has a collaboration with Google to develop COVID-19 tracking system for Android and iOS devices. Apple Inc. was founded in 1977 and is headquartered in Cupertino, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
O'BRIEN DEIRDRESenior Vice PresidentOct 16Sale119.8031,2003,737,869135,888Oct 19 06:32 PM
KONDO CHRISPrincipal Accounting OfficerOct 16Sale121.3414,8401,800,68626,876Oct 19 06:30 PM
Maestri LucaSenior Vice President, CFOOct 09Sale116.89243,43128,454,650110,272Oct 13 06:30 PM
WILLIAMS JEFFREY ECOOOct 02Sale113.59257,34329,232,596489,260Oct 05 06:33 PM
COOK TIMOTHY DChief Executive OfficerAug 25Sale496.91265,160131,761,779837,374Aug 25 06:45 PM
KONDO CHRISPrincipal Accounting OfficerMay 08Sale305.624,4911,372,5397,370May 12 06:30 PM
JUNG ANDREADirectorApr 28Option Exercise48.959,590469,38933,548Apr 30 09:30 PM
O'BRIEN DEIRDRESenior Vice PresidentApr 16Sale285.129,1372,605,14133,972Apr 17 06:31 PM
Maestri LucaSenior Vice President, CFOApr 07Sale264.4441,06210,858,44527,568Apr 09 06:30 PM
WILLIAMS JEFFREY ECOOApr 02Sale241.4441,0629,914,186108,329Apr 03 06:31 PM
LEVINSON ARTHUR DDirectorFeb 03Sale304.111,429434,5731,133,283Feb 04 06:34 PM
GORE ALBERT JRDirectorJan 27Option Exercise28.8632,889949,081113,585Jan 29 06:30 PM
LEVINSON ARTHUR DDirectorNov 05Option Exercise28.8637,3941,079,0821,170,677Nov 07 06:30 PM
LEVINSON ARTHUR DDirectorNov 05Sale257.7937,3949,639,7991,133,283Nov 07 06:30 PM
ABBV AbbVie Inc. daily Stock Chart
ABBV [NYSE]
AbbVie Inc.
IndexS&P 500 P/E17.71 EPS (ttm)4.55 Insider Own0.10% Shs Outstand1.76B Perf Week-2.90%
Market Cap142.00B Forward P/E6.65 EPS next Y12.10 Insider Trans-5.15% Shs Float1.76B Perf Month-7.37%
Income6.91B PEG1.89 EPS next Q2.77 Inst Own70.90% Short Float0.73% Perf Quarter-16.19%
Sales36.23B P/S3.92 EPS this Y42.30% Inst Trans0.11% Short Ratio1.80 Perf Half Y-2.08%
Book/sh8.93 P/B9.01 EPS next Y16.09% ROA7.10% Target Price109.12 Perf Year2.57%
Cash/sh3.42 P/C23.51 EPS next 5Y9.38% ROE-303.40% 52W Range62.55 - 101.28 Perf YTD-9.09%
Dividend4.72 P/FCF19.15 EPS past 5Y36.80% ROI21.20% 52W High-20.53% Beta0.67
Dividend %5.86% Quick Ratio0.70 Sales past 5Y10.80% Gross Margin73.30% 52W Low28.68% ATR1.71
Employees47000 Current Ratio0.90 Sales Q/Q26.30% Oper. Margin30.20% RSI (14)28.22 Volatility2.00% 1.84%
OptionableYes Debt/Eq5.94 EPS Q/Q-192.90% Profit Margin19.10% Rel Volume1.59 Prev Close82.71
ShortableYes LT Debt/Eq5.58 EarningsOct 30 BMO Payout98.80% Avg Volume7.20M Price80.49
Recom2.00 SMA20-6.26% SMA50-9.75% SMA200-9.40% Volume11,462,255 Change-2.68%
Sep-29-20Initiated Berenberg Hold $98
Jun-23-20Upgrade Atlantic Equities Neutral → Overweight $115
Jun-09-20Upgrade Wolfe Research Peer Perform → Outperform
Jun-02-20Upgrade Argus Hold → Buy $115
May-18-20Resumed BofA/Merrill Neutral $95
May-12-20Upgrade JP Morgan Neutral → Overweight $105
May-11-20Resumed Morgan Stanley Overweight $95
Apr-20-20Upgrade RBC Capital Mkts Sector Perform → Outperform $79 → $93
Mar-23-20Downgrade Societe Generale Buy → Hold
Feb-27-20Initiated Barclays Equal Weight $97
Feb-06-20Initiated Mizuho Buy
Jan-07-20Initiated RBC Capital Mkts Sector Perform $86
Dec-26-19Reiterated Cowen Outperform $90 → $98
Sep-26-19Upgrade Citigroup Neutral → Buy $87 → $90
Aug-20-19Upgrade Piper Jaffray Neutral → Overweight $80
Jun-27-19Upgrade Wolfe Research Underperform → Peer Perform
Jun-26-19Upgrade SVB Leerink Mkt Perform → Outperform $88
May-28-19Initiated Goldman Neutral
Apr-29-19Upgrade BMO Capital Markets Underperform → Market Perform
Mar-25-19Downgrade Argus Buy → Hold
Oct-28-20 06:51PM  
04:48PM  
12:08PM  
08:31AM  
08:00AM  
Oct-27-20 06:12AM  
Oct-26-20 05:45PM  
07:11AM  
Oct-23-20 12:30PM  
10:48AM  
10:05AM  
Oct-22-20 10:15AM  
Oct-21-20 11:45AM  
Oct-20-20 05:45PM  
11:52AM  
03:46AM  
Oct-19-20 06:55PM  
10:06AM  
09:27AM  
08:56AM  
Oct-17-20 06:50AM  
Oct-16-20 07:34PM  
11:04AM  
07:57AM  
05:16AM  
Oct-15-20 04:25PM  
01:34PM  
Oct-14-20 06:55AM  
Oct-13-20 05:45PM  
01:22PM  
12:48PM  
11:35AM  
Oct-09-20 06:14PM  
05:16PM  
02:02PM  
09:26AM  
09:00AM  
Oct-07-20 05:45PM  
03:28PM  
08:00AM  
Oct-06-20 08:00AM  
Oct-05-20 11:45AM  
06:00AM  
Oct-04-20 06:43AM  
Oct-02-20 03:21PM  
08:30AM  
Oct-01-20 01:55PM  
09:23AM  
06:01AM  
Sep-30-20 09:32AM  
09:15AM  
Sep-29-20 10:52AM  
Sep-28-20 05:45PM  
08:00AM  
07:23AM  
Sep-26-20 06:37AM  
Sep-24-20 07:53AM  
Sep-22-20 08:59AM  
Sep-21-20 05:45PM  
08:00AM  
Sep-18-20 01:13PM  
06:10AM  
06:04AM  
Sep-17-20 11:45AM  
10:00AM  
06:47AM  
Sep-16-20 08:00AM  
Sep-15-20 08:00PM  
04:53PM  
Sep-14-20 05:45PM  
08:00AM  
Sep-13-20 08:00PM  
02:43PM  
02:00PM  
Sep-12-20 08:30AM  
Sep-11-20 08:26PM  
11:30AM  
10:20AM  
09:39AM  
09:14AM  
06:40AM  
06:30AM  
Sep-10-20 01:52PM  
Sep-09-20 07:35PM  
01:52PM  
Sep-08-20 05:18PM  
Sep-07-20 12:36PM  
Sep-06-20 04:06AM  
Sep-04-20 01:41PM  
10:26AM  
10:08AM  
10:07AM  
07:50AM  
07:28AM  
07:15AM  
07:00AM  
Sep-03-20 08:00AM  
Sep-02-20 08:09AM  
Sep-01-20 04:13PM  
03:04PM  
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the United States, Japan, Germany, Canada, France, Spain, Italy, the Netherlands, the United Kingdom, Brazil, and internationally. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behcet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia (CLL), small lymphocytic lymphoma (SLL), mantle cell lymphoma, waldenstrom's macroglobulinemia, marginal zone lymphoma, and chronic graft versus host disease; VENCLEXTA, a BCL-2 inhibitor used to treat adults with CLL or SLL; VIEKIRA PAK, an interferon-free therapy to treat adults with genotype 1 chronic hepatitis C virus (HCV); TECHNIVIE to treat adults with genotype 4 HCV infection; and MAVYRET to treat patients with chronic HCV genotype 1-6 infection. It also provides SYNAGIS that protects at-risk infants from severe respiratory disease; KALETRA, a prescription anti-HIV-1 medicine; CREON, a pancreatic enzyme therapy for exocrine pancreatic insufficiency; Synthroid used in the treatment of hypothyroidism; AndroGel for males diagnosed with symptomatic low testosterone; and Lupron, a product for the palliative treatment of advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids. In addition, the company offers ORILISSA, a nonpeptide small molecule gonadotropin-releasing hormone antagonist; Duopa and Duodopa, a levodopa-carbidopa intestinal gel to treat Parkinson's disease; and Sevoflurane, an anesthesia product. It has collaborations with Calico Life Sciences LLC; Alector, Inc.; Janssen Biotech, Inc.; Jacobio Pharmaceuticals; I-Mab; and Genmab A/S. The company was incorporated in 2012 and is based in North Chicago, Illinois.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
ALBAN CARLOSVice ChairmanJul 07Sale100.0053,3255,332,555114,899Jul 08 09:19 PM
Stewart Jeffrey RyanSVP, US Commercial OperationsMay 12Sale90.0023,0242,072,21152,760May 12 05:44 PM
RICHMOND TIMOTHY J.EVP, Chief HR OfficerMay 05Sale85.0019,4451,652,8250May 07 05:01 PM
Durkin Brian LVP, ControllerMar 30Buy69.0075051,75016,844Mar 20 04:56 PM
Durkin Brian LVP, ControllerMar 20Buy67.5080054,00016,094Mar 20 04:56 PM
Durkin Brian LVP, ControllerMar 18Buy68.182,200150,00515,294Mar 20 04:56 PM
RAPP EDWARD JDirectorMar 03Buy87.872,875252,6172,875Mar 04 05:14 PM
AMD Advanced Micro Devices, Inc. daily Stock Chart
AMD [NASD]
Advanced Micro Devices, Inc.
IndexS&P 500 P/E151.89 EPS (ttm)0.50 Insider Own0.60% Shs Outstand1.17B Perf Week-3.54%
Market Cap86.92B Forward P/E45.83 EPS next Y1.67 Insider Trans-17.76% Shs Float1.17B Perf Month-6.57%
Income596.00M PEG4.24 EPS next Q0.35 Inst Own74.50% Short Float2.43% Perf Quarter-2.30%
Sales7.65B P/S11.37 EPS this Y-11.00% Inst Trans1.59% Short Ratio0.49 Perf Half Y45.83%
Book/sh2.82 P/B27.09 EPS next Y51.55% ROA10.30% Target Price80.79 Perf Year131.30%
Cash/sh1.56 P/C48.97 EPS next 5Y35.83% ROE21.50% 52W Range32.03 - 94.28 Perf YTD66.59%
Dividend- P/FCF142.26 EPS past 5Y20.70% ROI12.40% 52W High-18.96% Beta2.27
Dividend %- Quick Ratio1.60 Sales past 5Y4.10% Gross Margin44.40% 52W Low138.49% ATR3.09
Employees11400 Current Ratio2.10 Sales Q/Q26.20% Oper. Margin9.40% RSI (14)36.18 Volatility4.38% 3.46%
OptionableYes Debt/Eq0.21 EPS Q/Q305.40% Profit Margin8.00% Rel Volume1.31 Prev Close78.88
ShortableYes LT Debt/Eq0.15 EarningsOct 27 BMO Payout0.00% Avg Volume57.98M Price76.40
Recom2.50 SMA20-8.00% SMA50-6.81% SMA20024.53% Volume76,215,118 Change-3.14%
Oct-28-20Upgrade Craig Hallum Hold → Buy
Oct-28-20Upgrade Barclays Equal Weight → Overweight $85 → $100
Oct-12-20Initiated Truist Hold
Aug-24-20Downgrade Northland Capital Outperform → Market Perform
Aug-21-20Reiterated Cowen Outperform $90 → $100
Aug-04-20Reiterated Jefferies Buy $86 → $95
Jul-29-20Upgrade Susquehanna Neutral → Positive $85
Jul-29-20Upgrade Exane BNP Paribas Neutral → Outperform
Jul-29-20Reiterated Cowen Outperform $65 → $90
Jul-29-20Downgrade Craig Hallum Buy → Hold $60 → $66
Jul-14-20Reiterated Cowen Outperform $60 → $65
Jun-16-20Reiterated Morgan Stanley Equal-Weight $42 → $56
Mar-13-20Upgrade Northland Capital Market Perform → Outperform $52.50
Mar-06-20Upgrade Craig Hallum Hold → Buy $48 → $60
Mar-06-20Upgrade Atlantic Equities Neutral → Overweight $37 → $60
Mar-03-20Upgrade Piper Sandler Neutral → Overweight $45 → $56
Feb-20-20Downgrade Wells Fargo Overweight → Equal Weight $64
Feb-11-20Reiterated RBC Capital Mkts Outperform $53 → $63
Jan-29-20Upgrade Summit Insights Hold → Buy
Jan-29-20Downgrade Exane BNP Paribas Outperform → Neutral $47
Oct-28-20 10:13PM  
02:55PM  
02:45PM  
01:00PM  
12:54PM  
12:38PM  
12:29PM  
12:22PM  
11:27AM  
11:13AM  
10:10AM  
10:04AM  
09:44AM  
09:19AM  
09:01AM  
07:07AM  
Oct-27-20 09:03PM  
08:56PM  
08:26PM  
07:52PM  
07:08PM  
07:01PM  
06:57PM  
06:18PM  
05:42PM  
05:31PM  
04:53PM  
04:23PM  
04:15PM  
04:05PM  
04:02PM  
03:17PM  
03:05PM  
03:00PM  
02:28PM  
02:22PM  
02:19PM  
01:00PM  
01:00PM  
12:58PM  
12:24PM  
12:20PM  
12:05PM  
10:59AM  
10:47AM  
10:46AM  
10:33AM  
10:30AM  
10:29AM  
10:25AM  
10:23AM  
10:15AM  
10:12AM  
10:03AM  
09:56AM  
09:24AM  
08:58AM  
08:57AM  
07:45AM  
06:40AM  
06:35AM  
06:31AM  
06:30AM  
Oct-26-20 07:00PM  
05:47PM  
05:23PM  
04:49PM  
12:05PM  
12:04PM  
11:50AM  
10:36AM  
10:23AM  
10:04AM  
08:00AM  
06:50AM  
Oct-25-20 08:00AM  
Oct-23-20 06:48PM  
03:59PM  
03:06PM  
02:26PM  
01:44PM  
10:30AM  
09:58AM  
09:17AM  
08:18AM  
08:00AM  
07:00AM  
06:22AM  
Oct-22-20 07:43PM  
02:43PM  
01:19PM  
11:29AM  
11:07AM  
10:58AM  
08:16AM  
05:03AM  
04:41AM  
Oct-21-20 07:40PM  
07:20PM  
02:00PM  
Advanced Micro Devices, Inc. operates as a semiconductor company worldwide. The company operates in two segments, Computing and Graphics; and Enterprise, Embedded and Semi-Custom. Its products include x86 microprocessors as an accelerated processing unit, chipsets, discrete and integrated graphics processing units (GPUs), data center and professional GPUs, and development services; and server and embedded processors, and semi-custom System-on-Chip (SoC) products, development services, and technology for game consoles. The company provides x86 microprocessors for desktop PCs under the AMD Ryzen, AMD Ryzen PRO, Ryzen, Threadripper, AMD A-Series, AMD FX, AMD Athlon, AMD Athlon PRO, and AMD Pro A-Series processors brands; microprocessors for notebook and 2-in-1s under the AMD Ryzen processors with Radeon Vega GPUs, AMD A-Series, AMD Athlon, AMD Ryzen PRO, and AMD Pro A-Series processors brands; microprocessors for servers under the AMD EPYC and AMD Opteron brands; and chipsets under the AMD trademark. It also offers discrete GPUs for desktop and notebook PCs under the AMD Radeon graphics and AMD Embedded Radeon brands; professional graphics products under the AMD Radeon Pro and AMD FirePro graphics brands; and Radeon Instinct accelerators for servers. In addition, the company provides embedded processor solutions for interactive digital signage, casino gaming, and medical imaging under the AMD Opteron, AMD Athlon, AMD Geode, AMD Ryzen, AMD EPYC, AMD R-Series, and G-Series processors brands; and customer-specific solutions based on AMD CPU, GPU, and multi-media technologies, as well as semi-custom SoC products. It serves original equipment and design manufacturers, datacenters, original design manufacturers, system integrators, independent distributors, online retailers, and add-in-board manufacturers through its direct sales force, independent distributors, and sales representatives. The company was founded in 1969 and is headquartered in Santa Clara, California.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Norrod Forrest EugeneSVP & GM DESGOct 19Option Exercise4.2837,500160,462751,245Oct 21 04:12 PM
Norrod Forrest EugeneSVP & GM DESGOct 19Sale83.8775,0006,290,286676,245Oct 21 04:12 PM
Papermaster Mark DChief Technology Officer & EVPOct 15Option Exercise4.0843,000175,4401,465,329Oct 19 04:14 PM
Papermaster Mark DChief Technology Officer & EVPOct 15Sale84.1743,0003,619,2231,422,329Oct 19 04:14 PM
Papermaster Mark DChief Technology Officer & EVPSep 15Option Exercise4.0843,000175,4401,465,329Sep 17 04:14 PM
Papermaster Mark DChief Technology Officer & EVPSep 15Sale77.2243,0003,320,4421,422,329Sep 17 04:14 PM
Su Lisa TPresident & CEOSep 09Option Exercise2.80150,000420,0002,857,040Sep 11 04:08 PM
Su Lisa TPresident & CEOSep 09Sale81.08150,00012,161,7362,707,040Sep 11 04:08 PM
Norrod Forrest EugeneSVP & GM DESGSep 08Option Exercise2.6137,50097,875788,745Sep 10 04:08 PM
Norrod Forrest EugeneSVP & GM DESGSep 08Sale79.5075,0005,962,758713,745Sep 10 04:08 PM
KUMAR DEVINDERSVP, CFO & TreasurerSep 01Sale92.0214,3451,320,027522,550Sep 03 04:13 PM
GRASBY PAUL DARRENSVP & CSO, President EMEAAug 26Sale86.9910,000869,90031,988Aug 28 04:09 PM
Bergman RickEVP, Computing & GraphicsAug 25Sale83.342,000166,68075,891Aug 27 04:16 PM
Su Lisa TPresident & CEOAug 15Option Exercise0.00377,13602,855,444Aug 18 04:24 PM
KUMAR DEVINDERSVP, CFO & TreasurerAug 15Option Exercise0.0094,2840583,642Aug 18 04:20 PM
WOLIN HARRY ASVP, GC & Corporate SecretaryAug 15Option Exercise0.0070,71301,559,674Aug 18 04:17 PM
Norrod Forrest EugeneSVP & GM DESGAug 15Option Exercise0.0094,2840788,346Aug 18 04:15 PM
Papermaster Mark DChief Technology Officer & EVPAug 15Option Exercise0.00106,06901,464,068Aug 18 04:25 PM
Papermaster Mark DChief Technology Officer & EVPAug 14Option Exercise4.0843,000175,4401,400,999Aug 18 04:25 PM
SMITH DARLA MChief Accounting OfficerAug 14Sale81.227,870639,20114,283Aug 18 04:29 PM
Papermaster Mark DChief Technology Officer & EVPAug 14Sale82.3543,0003,541,2621,357,999Aug 18 04:25 PM
KUMAR DEVINDERSVP, CFO & TreasurerAug 11Option Exercise4.0862,765256,081552,123Aug 13 04:16 PM
Su Lisa TPresident & CEOAug 11Option Exercise2.80150,000420,0002,628,308Aug 13 04:12 PM
KUMAR DEVINDERSVP, CFO & TreasurerAug 11Sale79.6462,7654,998,880489,358Aug 13 04:16 PM
Su Lisa TPresident & CEOAug 11Sale79.14150,00011,870,4372,478,308Aug 13 04:12 PM
Bergman RickEVP, Computing & GraphicsAug 09Option Exercise0.0047,7980100,143Aug 11 04:46 PM
SMITH DARLA MChief Accounting OfficerAug 09Option Exercise0.0010,649026,062Aug 11 04:43 PM
KUMAR DEVINDERSVP, CFO & TreasurerAug 09Option Exercise0.0028,4560503,469Aug 11 04:38 PM
Su Lisa TPresident & CEOAug 09Option Exercise0.00123,06702,526,737Aug 11 04:33 PM
Papermaster Mark DChief Technology Officer & EVPAug 09Option Exercise0.0037,46201,372,742Aug 11 04:29 PM
WOLIN HARRY ASVP, GC & Corporate SecretaryAug 09Option Exercise0.0020,91301,497,192Aug 11 04:25 PM
GRASBY PAUL DARRENSVP & CSO, President EMEAAug 09Option Exercise0.0030,098056,135Aug 11 04:23 PM
Norrod Forrest EugeneSVP & GM DESGAug 09Option Exercise0.0027,9710705,071Aug 11 04:19 PM
Denzel NoraDirectorJul 31Sale78.7575,0005,906,25084,560Aug 04 04:17 PM
Norrod Forrest EugeneSVP & GM DESGJul 20Option Exercise2.6137,50097,875752,100Jul 22 04:17 PM
Norrod Forrest EugeneSVP & GM DESGJul 20Sale55.2575,0004,143,750677,100Jul 22 04:17 PM
Papermaster Mark DChief Technology Officer & EVPJul 15Option Exercise4.0843,000175,4401,378,280Jul 17 04:10 PM
Papermaster Mark DChief Technology Officer & EVPJul 15Sale54.3643,0002,337,4801,335,280Jul 17 04:10 PM
Papermaster Mark DChief Technology Officer & EVPJun 15Option Exercise4.0843,000175,4401,378,280Jun 17 04:18 PM
Papermaster Mark DChief Technology Officer & EVPJun 15Sale52.9043,0002,274,8261,335,280Jun 17 04:18 PM
Su Lisa TPresident & CEOJun 09Option Exercise2.80150,000420,0002,753,670Jun 11 04:13 PM
Su Lisa TPresident & CEOJun 09Sale55.41150,0008,311,7652,403,670Jun 11 04:13 PM
KUMAR DEVINDERSVP, CFO & TreasurerJun 02Option Exercise4.0862,764256,077537,777Jun 04 04:06 PM
KUMAR DEVINDERSVP, CFO & TreasurerJun 02Sale53.0662,7643,330,258475,013Jun 04 04:06 PM
Norrod Forrest EugeneSVP & GM DESGJun 01Option Exercise2.6137,50097,875789,600Jun 03 04:19 PM
GRASBY PAUL DARRENSVP & CSO, President EMEAJun 01Option Exercise1.843,5486,52844,585Jun 03 04:22 PM
GRASBY PAUL DARRENSVP & CSO, President EMEAJun 01Sale53.3018,548988,60826,037Jun 03 04:22 PM
Norrod Forrest EugeneSVP & GM DESGJun 01Sale53.6675,0004,024,194714,600Jun 03 04:19 PM
SMITH DARLA MChief Accounting OfficerMay 18Sale54.881371315,413May 19 04:47 PM
SMITH DARLA MChief Accounting OfficerMay 15Option Exercise0.0036015,426May 19 04:47 PM
Denzel NoraDirectorMay 15Option Exercise0.006,6610159,560May 19 04:45 PM
Papermaster Mark DChief Technology Officer & EVPMay 15Option Exercise4.0843,000175,4401,378,280May 19 05:22 PM
Papermaster Mark DChief Technology Officer & EVPMay 15Sale53.7143,0002,309,5301,335,280May 19 05:22 PM
KUMAR DEVINDERSVP, CFO & TreasurerMay 12Option Exercise4.0862,764256,077537,777May 14 04:14 PM
Su Lisa TPresident & CEOMay 12Option Exercise2.80150,000420,0002,753,670May 14 04:19 PM
Su Lisa TPresident & CEOMay 12Sale55.43150,0008,314,6912,603,670May 14 04:19 PM
KUMAR DEVINDERSVP, CFO & TreasurerMay 12Sale55.6862,7643,494,833475,013May 14 04:14 PM
Norrod Forrest EugeneSVP & GM DESGApr 20Option Exercise2.6137,50097,875827,100Apr 22 04:18 PM
Norrod Forrest EugeneSVP & GM DESGApr 20Sale57.0675,0004,279,269752,100Apr 22 04:18 PM
Papermaster Mark DChief Technology Officer & EVPApr 15Option Exercise4.0843,000175,4401,378,280Apr 17 04:52 PM
Papermaster Mark DChief Technology Officer & EVPApr 15Sale53.8443,0002,315,1201,335,280Apr 17 04:52 PM
Su Lisa TPresident & CEOMar 10Option Exercise2.80150,000420,0002,753,670Mar 12 04:08 PM
Su Lisa TPresident & CEOMar 10Sale44.53150,0006,680,1052,603,670Mar 12 04:08 PM
KUMAR DEVINDERSVP, CFO & TreasurerMar 03Option Exercise4.0862,764256,077537,777Mar 05 04:45 PM
KUMAR DEVINDERSVP, CFO & TreasurerMar 03Sale48.8262,7643,063,825475,013Mar 05 04:45 PM
Norrod Forrest EugeneSVP & GM DESGMar 02Option Exercise2.6137,50097,875864,600Mar 03 04:12 PM
Norrod Forrest EugeneSVP & GM DESGMar 02Sale46.0275,0003,451,734789,600Mar 03 04:12 PM
KUMAR DEVINDERSVP, CFO & TreasurerFeb 20Option Exercise4.0862,764256,077537,777Feb 24 04:20 PM
KUMAR DEVINDERSVP, CFO & TreasurerFeb 20Sale58.2462,7643,655,375475,013Feb 24 04:20 PM
GRASBY PAUL DARRENSVP & CSO, President EMEAFeb 20Sale58.496,000350,94041,037Feb 24 04:16 PM
GRASBY PAUL DARRENSVP & CSO, President EMEAFeb 18Sale54.9017,922983,91847,037Feb 19 04:43 PM
GRASBY PAUL DARRENSVP & CSO, President EMEAFeb 15Option Exercise0.0037,846064,959Feb 19 04:43 PM
Su Lisa TPresident & CEOFeb 11Option Exercise2.80150,000420,0002,753,670Feb 13 06:23 PM
Su Lisa TPresident & CEOFeb 11Sale53.94150,0008,090,5402,603,670Feb 13 06:23 PM
WOLIN HARRY ASVP, GC & Corporate SecretaryFeb 10Option Exercise4.08153,984628,2551,630,263Feb 12 04:10 PM
WOLIN HARRY ASVP, GC & Corporate SecretaryFeb 10Sale50.81153,9847,823,9271,476,279Feb 12 04:10 PM
Norrod Forrest EugeneSVP & GM DESGJan 21Option Exercise2.6137,50097,875902,100Jan 23 04:17 PM
Norrod Forrest EugeneSVP & GM DESGJan 21Sale51.4175,0003,855,750827,100Jan 23 04:17 PM
Papermaster Mark DChief Technology Officer & EVPDec 13Option Exercise3.9030,000117,0001,365,280Dec 17 04:21 PM
Papermaster Mark DChief Technology Officer & EVPDec 13Sale42.3930,0001,271,7001,335,280Dec 17 04:21 PM
Su Lisa TPresident & CEODec 09Option Exercise4.0878,143318,8232,780,410Dec 11 04:10 PM
Su Lisa TPresident & CEODec 09Sale39.35128,1435,042,4272,652,267Dec 11 04:10 PM
SMITH DARLA MChief Accounting OfficerDec 06Sale39.685,000198,40014,948Dec 10 04:09 PM
GRASBY PAUL DARRENSVP & CSO, President EMEADec 04Sale39.386,000236,28027,113Dec 06 04:13 PM
Norrod Forrest EugeneSVP & GM DESGNov 25Option Exercise2.6125,00065,250914,600Nov 27 04:28 PM
Norrod Forrest EugeneSVP & GM DESGNov 25Sale39.7150,0001,985,500864,600Nov 27 04:28 PM
WOLIN HARRY ASVP, GC & Corporate SecretaryNov 19Option Exercise11.4157,325654,2881,541,454Nov 21 04:13 PM
WOLIN HARRY ASVP, GC & Corporate SecretaryNov 19Sale40.1957,3252,303,8921,484,129Nov 21 04:13 PM
SMITH DARLA MChief Accounting OfficerNov 18Sale38.6383132,10219,948Nov 19 06:20 PM
SMITH DARLA MChief Accounting OfficerNov 15Option Exercise0.001,666020,779Nov 19 06:20 PM
Papermaster Mark DChief Technology Officer & EVPNov 15Option Exercise3.9030,000117,0001,365,280Nov 19 04:18 PM
Papermaster Mark DChief Technology Officer & EVPNov 15Sale39.1330,0001,173,9001,335,280Nov 19 04:18 PM
Su Lisa TPresident & CEONov 07Option Exercise4.0878,500320,2802,830,767Nov 12 04:11 PM
Su Lisa TPresident & CEONov 07Sale36.54128,5004,695,3902,702,267Nov 12 04:11 PM
KUMAR DEVINDERSVP, CFO & TreasurerOct 30Sale32.75128,2404,199,860475,013Nov 01 04:09 PM
BABA Alibaba Group Holding Limited daily Stock Chart
BABA [NYSE]
Alibaba Group Holding Limited
Index- P/E31.37 EPS (ttm)9.82 Insider Own25.37% Shs Outstand2.70B Perf Week-0.01%
Market Cap823.39B Forward P/E25.73 EPS next Y11.97 Insider Trans0.00% Shs Float1.85B Perf Month11.20%
Income26.28B PEG8.82 EPS next Q2.13 Inst Own46.80% Short Float2.51% Perf Quarter21.84%
Sales82.09B P/S10.03 EPS this Y67.50% Inst Trans-0.14% Short Ratio3.66 Perf Half Y51.94%
Book/sh44.86 P/B6.86 EPS next Y26.49% ROA13.60% Target Price322.29 Perf Year74.09%
Cash/sh21.63 P/C14.23 EPS next 5Y3.56% ROE24.10% 52W Range169.95 - 319.32 Perf YTD45.19%
Dividend- P/FCF33.51 EPS past 5Y42.10% ROI6.70% 52W High-3.56% Beta1.30
Dividend %- Quick Ratio2.00 Sales past 5Y46.20% Gross Margin44.10% 52W Low81.19% ATR8.62
Employees120535 Current Ratio2.00 Sales Q/Q33.80% Oper. Margin18.60% RSI (14)56.60 Volatility3.11% 2.64%
OptionableYes Debt/Eq0.16 EPS Q/Q115.20% Profit Margin32.00% Rel Volume1.07 Prev Close317.14
ShortableYes LT Debt/Eq0.15 EarningsNov 05 BMO Payout0.00% Avg Volume12.68M Price307.94
Recom1.60 SMA202.04% SMA507.46% SMA20031.32% Volume13,555,085 Change-2.90%
Aug-24-20Reiterated Barclays Overweight $300 → $320
Aug-21-20Reiterated The Benchmark Company Buy $275 → $290
Jul-09-20Initiated Needham Buy $275
Feb-14-20Reiterated The Benchmark Company Buy $220 → $275
Jan-22-20Initiated DZ Bank Buy $260
Nov-22-19Initiated Macquarie Outperform
Oct-04-19Reiterated HSBC Securities Buy $230 → $233
Aug-05-19Initiated Jefferies Buy
Jun-04-19Initiated Loop Capital Buy
May-16-19Reiterated The Benchmark Company Buy $205 → $220
May-07-19Reiterated KeyBanc Capital Markets Overweight $210 → $240
Jan-31-19Reiterated SunTrust Buy $180 → $200
Jan-31-19Reiterated Stifel Buy $175 → $180
Jan-31-19Reiterated Nomura Buy $200 → $205
Jan-31-19Reiterated Macquarie Outperform $220 → $224
Jan-31-19Reiterated KeyBanc Capital Mkts Overweight $200 → $210
Jan-31-19Reiterated Citigroup Buy $208 → $211
Jan-31-19Reiterated BofA/Merrill Buy $221 → $215
Jan-31-19Reiterated Barclays Overweight $195 → $200
Jan-14-19Resumed Bernstein Mkt Perform
Oct-28-20 09:09PM  
09:48AM  
09:30AM  
02:57AM  
02:22AM  
Oct-27-20 07:56PM  
04:59PM  
11:59AM  
11:12AM  
11:08AM  
06:25AM  
05:30AM  
12:29AM  
Oct-26-20 10:28PM  
10:09PM  
04:21PM  
04:05PM  
02:29PM  
11:45AM  
10:43AM  
10:40AM  
08:59AM  
08:58AM  
06:02AM  
Oct-25-20 11:14PM  
09:31PM  
Oct-24-20 12:50AM  
12:32AM  
Oct-23-20 12:30PM  
11:06AM  
07:10AM  
06:01AM  
05:30AM  
Oct-22-20 02:14PM  
12:22PM  
10:23AM  
10:05AM  
08:05AM  
07:29AM  
05:55AM  
05:00AM  
Oct-21-20 11:44PM  
11:43PM  
11:31PM  
01:25PM  
01:08PM  
Oct-20-20 08:11PM  
06:00PM  
04:20PM  
11:06AM  
10:25AM  
09:48AM  
08:30AM  
08:30AM  
04:40AM  
02:43AM  
01:34AM  
12:00AM  
Oct-19-20 10:05PM  
04:29PM  
03:55PM  
03:20PM  
02:16PM  
01:17PM  
01:00PM  
06:50AM  
02:13AM  
02:11AM  
02:07AM  
02:05AM  
01:32AM  
12:46AM  
Oct-18-20 10:46PM  
10:24PM  
09:50PM  
08:05PM  
Oct-16-20 04:27PM  
03:28PM  
03:11PM  
09:03AM  
05:54AM  
05:30AM  
01:06AM  
Oct-15-20 11:20PM  
05:00PM  
03:25PM  
11:20AM  
10:32AM  
06:23AM  
03:23AM  
01:50AM  
01:00AM  
Oct-14-20 03:11PM  
Oct-13-20 04:13PM  
03:56PM  
11:23AM  
10:54AM  
10:08AM  
01:51AM  
Alibaba Group Holding Limited, through its subsidiaries, provides online and mobile commerce businesses in the People's Republic of China and internationally. It operates through four segments: Core Commerce, Cloud Computing, Digital Media and Entertainment, and Innovation Initiatives and Others. The company operates Taobao Marketplace, a mobile commerce destination; Tmall, a third-party online and mobile commerce platform for brands and retailers; Alibaba Health Internet platforms for pharmaceutical and healthcare products; Alimama, a monetization platform; 1688.com and Alibaba.com, which are online wholesale marketplaces; AliExpress, a retail marketplace; Lazada, an e-commerce platform; and Tmall Global, an import e-commerce platform. It also operates Lingshoutong, a digital sourcing platform; Cainiao Network logistic services platform; Ele.me, a delivery and local services platform; Koubei, a restaurant and local services guide platform; and Fliggy, an online travel platform. In addition, the company offers pay-for-performance and display marketing services; and Taobao Ad Network and Exchange, a real-time bidding online marketing exchange. Further, it provides elastic computing, database, storage, virtualization network, large-scale computing, security, management and application, big data analytics, and Internet of Things and other services for enterprises; payment and escrow services; and movies, television series, variety shows, animations, and other video content. Additionally, the company operates Youku, an online video platform; Alibaba Pictures and other content platforms that provide online videos, films, live events, news feeds, literature, music, and others; Amap, a mobile digital map, navigation, and real-time traffic information app; DingTalk, a business efficiency app; and Tmall Genie, an AI-powered smart speaker. The company was founded in 1999 and is based in Hangzhou, the People's Republic of China.
BAC Bank of America Corporation daily Stock Chart
BAC [NYSE]
Bank of America Corporation
IndexS&P 500 P/E11.60 EPS (ttm)2.02 Insider Own0.10% Shs Outstand8.74B Perf Week-2.41%
Market Cap203.10B Forward P/E11.37 EPS next Y2.07 Insider Trans0.00% Shs Float8.66B Perf Month-1.26%
Income18.01B PEG22.34 EPS next Q0.50 Inst Own72.50% Short Float0.78% Perf Quarter-5.52%
Sales57.05B P/S3.56 EPS this Y5.60% Inst Trans1.62% Short Ratio1.16 Perf Half Y-2.41%
Book/sh27.71 P/B0.85 EPS next Y18.27% ROA0.90% Target Price28.80 Perf Year-26.82%
Cash/sh117.67 P/C0.20 EPS next 5Y0.52% ROE9.30% 52W Range17.95 - 35.72 Perf YTD-33.36%
Dividend0.72 P/FCF3.38 EPS past 5Y45.50% ROI6.00% 52W High-34.29% Beta1.58
Dividend %3.07% Quick Ratio- Sales past 5Y6.60% Gross Margin- 52W Low30.75% ATR0.70
Employees213000 Current Ratio- Sales Q/Q-31.20% Oper. Margin72.40% RSI (14)40.69 Volatility2.51% 2.53%
OptionableYes Debt/Eq0.00 EPS Q/Q-49.60% Profit Margin39.70% Rel Volume1.41 Prev Close23.85
ShortableYes LT Debt/Eq1.08 EarningsOct 14 BMO Payout28.00% Avg Volume58.02M Price23.47
Recom2.30 SMA20-4.12% SMA50-5.75% SMA200-8.43% Volume81,716,601 Change-1.59%
Sep-03-20Upgrade Deutsche Bank Hold → Buy $27 → $29
Jul-09-20Downgrade DA Davidson Buy → Neutral $27 → $25
Jul-08-20Initiated Seaport Global Securities Neutral
Jul-07-20Upgrade Societe Generale Hold → Buy
Apr-14-20Upgrade Societe Generale Sell → Hold
Apr-02-20Upgrade DA Davidson Neutral → Buy $36 → $24
Mar-25-20Downgrade Wolfe Research Outperform → Peer Perform
Mar-17-20Upgrade Robert W. Baird Neutral → Outperform $34
Jan-21-20Downgrade Atlantic Equities Overweight → Neutral
Jan-09-20Initiated DA Davidson Neutral $36
Jan-07-20Downgrade UBS Buy → Neutral $34 → $36
Jan-06-20Upgrade Barclays Equal Weight → Overweight $43
Jan-03-20Downgrade BMO Capital Markets Outperform → Market Perform $37
Oct-29-19Downgrade Societe Generale Hold → Sell
Oct-28-19Upgrade Odeon Hold → Buy
Oct-22-19Upgrade Atlantic Equities Neutral → Overweight
Sep-06-19Downgrade Keefe Bruyette Outperform → Mkt Perform $36 → $29
Aug-29-19Downgrade Raymond James Outperform → Mkt Perform
Jul-26-19Upgrade Keefe Bruyette Mkt Perform → Outperform $32 → $36
Jun-18-19Upgrade BMO Capital Markets Market Perform → Outperform
Oct-28-20 04:25PM  
08:14AM  
07:22AM  
Oct-27-20 07:09PM  
06:29PM  
05:09PM  
11:18AM  
Oct-26-20 07:08PM  
04:59PM  
09:53AM  
09:24AM  
09:11AM  
07:30AM  
Oct-25-20 09:48AM  
Oct-24-20 08:00AM  
Oct-23-20 04:25PM  
Oct-22-20 07:35PM  
05:16PM  
04:53PM  
04:25PM  
06:29AM  
06:15AM  
06:06AM  
Oct-21-20 11:43PM  
10:16PM  
04:25PM  
04:15PM  
Oct-20-20 04:25PM  
11:44AM  
04:40AM  
Oct-19-20 10:05PM  
04:25PM  
12:35PM  
11:56AM  
Oct-18-20 07:23PM  
07:46AM  
Oct-17-20 09:15AM  
Oct-16-20 08:55PM  
04:25PM  
11:40AM  
10:55AM  
10:24AM  
09:14AM  
09:03AM  
01:43AM  
Oct-15-20 08:08PM  
04:26PM  
04:10PM  
11:47AM  
10:05AM  
Oct-14-20 11:30PM  
06:05PM  
05:56PM  
04:37PM  
04:25PM  
04:23PM  
04:10PM  
02:42PM  
02:41PM  
12:33PM  
12:11PM  
12:04PM  
11:37AM  
11:20AM  
11:15AM  
11:01AM  
10:56AM  
10:39AM  
10:37AM  
10:37AM  
10:01AM  
10:01AM  
09:50AM  
08:58AM  
07:46AM  
07:16AM  
07:03AM  
06:57AM  
04:15AM  
02:32AM  
Oct-13-20 04:33PM  
04:25PM  
04:15PM  
04:13PM  
12:15PM  
12:15PM  
11:58AM  
11:09AM  
10:39AM  
10:08AM  
09:57AM  
Oct-12-20 04:57PM  
04:25PM  
03:46PM  
03:28PM  
11:27AM  
11:01AM  
10:33AM  
09:51AM  
08:54AM  
Bank of America Corporation, through its subsidiaries, provides banking and financial products and services for individual consumers, small- and middle-market businesses, institutional investors, large corporations, and governments worldwide. It operates in Consumer Banking, Global Wealth & Investment Management (GWIM), Global Banking, and Global Markets segments. The Consumer Banking segment offers traditional and money market savings accounts, CDs and IRAs, noninterest- and interest-bearing checking accounts, and investment accounts and products; and credit and debit cards, residential mortgages, and home equity loans, as well as direct and indirect loans, such as automotive, recreational vehicle, and consumer personal loans. The GWIM segment offers investment management, brokerage, banking, and trust and retirement products; and wealth management solutions, as well as customized solutions, including specialty asset management services. The Global Banking segment provides lending products and services, including commercial loans, leases, commitment facilities, trade finance, and real estate and asset-based lending; treasury solutions, such as treasury management, foreign exchange, and short-term investing options; working capital management solutions; and debt and equity underwriting and distribution, and merger-related and other advisory services. The Global Markets segment offers market-making, financing, securities clearing, settlement, and custody services, as well as risk management, fixed-income, and mortgage-related products. As of May 7, 2020, it served approximately 66 million consumer and small business clients with approximately 4,300 retail financial centers; approximately 16,900 ATMs; and digital banking platforms with approximately 39 million active users. Bank of America Corporation was founded in 1784 and is headquartered in Charlotte, North Carolina.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BANK OF AMERICA CORP /DE/10% OwnerDec 29Buy14.705745Mar 17 06:12 PM
BANK OF AMERICA CORP /DE/10% OwnerDec 21Buy14.703443Mar 17 06:12 PM
MOYNIHAN BRIAN TChairman and CEOSep 15Option Exercise0.0018,13201,807,251Sep 17 04:04 PM
BANK OF AMERICA CORP /DE/10% OwnerSep 14Buy15.291652,523165Mar 17 06:12 PM
MOYNIHAN BRIAN TChairman and CEOJun 15Option Exercise0.0018,13201,807,251Jun 17 04:02 PM
MOYNIHAN BRIAN TChairman and CEOMay 15Option Exercise0.0018,13201,807,251May 19 04:02 PM
MOYNIHAN BRIAN TChairman and CEOApr 15Option Exercise0.0018,13201,807,251Apr 17 04:02 PM
MOYNIHAN BRIAN TChairman and CEOMar 15Option Exercise0.0018,13101,807,250Mar 17 04:02 PM
BANK OF AMERICA CORP /DE/10% OwnerMar 13Buy15.211150Mar 17 03:26 PM
MOYNIHAN BRIAN TChairman and CEOJan 15Option Exercise0.0021,83801,508,536Jan 17 04:01 PM
BANK OF AMERICA CORP /DE/10% OwnerJan 12Sale12.491,30016,2310May 03 02:33 PM
MOYNIHAN BRIAN TChairman and CEODec 15Option Exercise0.0021,83801,508,536Dec 17 04:02 PM
MOYNIHAN BRIAN TChairman and CEONov 15Option Exercise0.0021,83801,523,536Nov 19 04:54 PM
BBBY Bed Bath & Beyond Inc. daily Stock Chart
BBBY [NASD]
Bed Bath & Beyond Inc.
Index- P/E- EPS (ttm)-1.88 Insider Own2.50% Shs Outstand124.15M Perf Week-13.67%
Market Cap2.64B Forward P/E20.57 EPS next Y1.03 Insider Trans1.30% Shs Float118.66M Perf Month45.42%
Income-231.40M PEG- EPS next Q0.14 Inst Own- Short Float57.11% Perf Quarter92.52%
Sales9.86B P/S0.27 EPS this Y-383.10% Inst Trans-0.01% Short Ratio6.93 Perf Half Y240.87%
Book/sh13.67 P/B1.54 EPS next Y258.20% ROA-2.40% Target Price20.29 Perf Year42.57%
Cash/sh11.53 P/C1.83 EPS next 5Y- ROE-11.10% 52W Range3.43 - 26.16 Perf YTD21.97%
Dividend0.68 P/FCF14.09 EPS past 5Y-24.40% ROI-16.40% 52W High-19.34% Beta2.59
Dividend %3.22% Quick Ratio0.70 Sales past 5Y-1.20% Gross Margin33.10% 52W Low515.16% ATR1.55
Employees55000 Current Ratio1.50 Sales Q/Q-1.20% Oper. Margin-2.30% RSI (14)50.39 Volatility6.23% 6.65%
OptionableYes Debt/Eq0.76 EPS Q/Q255.90% Profit Margin-1.90% Rel Volume2.02 Prev Close24.01
ShortableYes LT Debt/Eq0.76 EarningsOct 01 BMO Payout- Avg Volume9.78M Price21.10
Recom2.70 SMA20-6.20% SMA5027.57% SMA20091.40% Volume19,746,735 Change-12.12%
Oct-02-20Reiterated Telsey Advisory Group Market Perform $13 → $23
Sep-24-20Upgrade Robert W. Baird Neutral → Outperform $13 → $20
May-26-20Upgrade Odeon Hold → Buy
Apr-03-20Reiterated Telsey Advisory Group Market Perform $7 → $4
Mar-23-20Downgrade Telsey Advisory Group Outperform → Market Perform $15 → $7
Mar-23-20Downgrade Odeon Buy → Hold
Mar-20-20Downgrade KeyBanc Capital Markets Overweight → Sector Weight
Mar-16-20Downgrade Morgan Stanley Equal-Weight → Underweight
Jan-24-20Initiated Odeon Buy $24
Dec-17-19Reiterated Telsey Advisory Group Outperform $16 → $18
Oct-15-19Upgrade KeyBanc Capital Markets Sector Weight → Overweight $18
Oct-10-19Upgrade Telsey Advisory Group Market Perform → Outperform $14 → $16
Sep-30-19Upgrade Wedbush Neutral → Outperform $14 → $16
Aug-20-19Reiterated BofA/Merrill Buy $25 → $20
Aug-09-19Upgrade Evercore ISI Underperform → In-line
Jul-11-19Initiated Goldman Sell $11
Jul-03-19Reiterated Telsey Advisory Group Market Perform $20 → $14
Apr-11-19Reiterated Telsey Advisory Group Market Perform $18 → $20
Apr-05-19Upgrade Morgan Stanley Underweight → Equal-Weight
Apr-01-19Upgrade Citigroup Sell → Neutral $10 → $18
Oct-28-20 01:35PM  
12:48PM  
10:29AM  
09:40AM  
07:25AM  
07:09AM  
07:05AM  
07:00AM  
Oct-26-20 01:57PM  
01:43PM  
08:30AM  
Oct-23-20 12:00PM  
Oct-22-20 11:50AM  
08:00AM  
Oct-21-20 03:15PM  
11:30AM  
Oct-20-20 12:50PM  
12:41PM  
Oct-19-20 11:59AM  
Oct-17-20 05:45AM  
Oct-16-20 01:28PM  
01:18PM  
09:26AM  
Oct-15-20 11:40AM  
10:30AM  
09:32AM  
Oct-14-20 04:53PM  
03:30PM  
11:37AM  
11:11AM  
10:35AM  
10:31AM  
10:23AM  
08:50AM  
07:25AM  
01:56AM  
Oct-13-20 08:19PM  
05:21PM  
04:30PM  
12:49PM  
Oct-12-20 01:07PM  
09:25AM  
Oct-09-20 08:42AM  
Oct-08-20 01:07PM  
Oct-07-20 07:50PM  
03:40PM  
12:00PM  
Oct-06-20 11:50AM  
10:38AM  
07:30AM  
07:30AM  
Oct-05-20 02:32PM  
11:31AM  
11:18AM  
09:18AM  
09:15AM  
09:05AM  
08:26AM  
03:27AM  
Oct-03-20 10:43AM  
10:43AM  
Oct-02-20 06:37PM  
05:02PM  
04:18PM  
01:36PM  
01:30PM  
12:43PM  
09:50AM  
09:38AM  
08:01AM  
03:00AM  
Oct-01-20 06:47PM  
04:31PM  
01:37PM  
01:07PM  
12:52PM  
12:50PM  
12:18PM  
12:14PM  
11:18AM  
11:16AM  
11:00AM  
10:45AM  
10:23AM  
09:59AM  
09:43AM  
08:37AM  
08:25AM  
07:34AM  
07:09AM  
07:00AM  
06:00AM  
Sep-30-20 01:55PM  
10:11AM  
Sep-29-20 03:35PM  
02:26PM  
10:08AM  
08:00AM  
Sep-28-20 03:13PM  
10:02AM  
Bed Bath & Beyond Inc., together with its subsidiaries, operates a chain of retail stores. The company sells a range of domestics merchandise, including bed linens and related items, bath items, and kitchen textiles; and home furnishings, such as kitchen and tabletop items, fine tabletop, basic housewares, general home furnishings, consumables, and various juvenile products. It also provides various textile products, amenities, and other goods to institutional customers in the hospitality, cruise line, healthcare, and other industries. As of February 29, 2020, the company had 1,500 stores, including 976 Bed Bath & Beyond stores in the United States and Canada; 261 stores under the names of World Market, Cost Plus World Market, or Cost Plus; 126 Buy Buy BABY stores; 81 stores under the Christmas Tree Shops, Christmas Tree Shops andThat! Names; and 53 stores under the Harmon, Harmon Face Values, or Face Values names. It also offers products through various Websites and applications, such as bedbathandbeyond.com, bedbathandbeyond.ca, harmondiscount.com, facevalues.com, christmastreeshops.com, andthat.com, buybuybaby.com, buybuybaby.ca, harborlinen.com, t-ygroup.com, worldmarket.com, personalizationmall.com, and decorist.com. In addition, it operates PersonalizationMall.com, an online retailer of personalized products; and Decorist, an online interior design platform. The company was founded in 1971 and is headquartered in Union, New Jersey.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
GOVE SUEDirectorJul 13Buy7.8934,000268,26042,342Jul 14 06:25 PM
Yerger AnnDirectorJul 10Buy8.296,00049,74017,371Jul 14 06:09 PM
BBD Banco Bradesco S.A. daily Stock Chart
BBD [NYSE]
Banco Bradesco S.A.
Index- P/E5.14 EPS (ttm)0.70 Insider Own0.01% Shs Outstand8.84B Perf Week-6.74%
Market Cap31.81B Forward P/E7.06 EPS next Y0.51 Insider Trans0.00% Shs Float6.34B Perf Month6.94%
Income- PEG3.21 EPS next Q0.09 Inst Own20.17% Short Float0.07% Perf Quarter-20.48%
Sales- P/S- EPS this Y-44.60% Inst Trans- Short Ratio0.22 Perf Half Y2.87%
Book/sh4.55 P/B0.79 EPS next Y24.40% ROA- Target Price6.26 Perf Year-55.20%
Cash/sh- P/C- EPS next 5Y1.60% ROE- 52W Range2.67 - 8.38 Perf YTD-55.28%
Dividend0.04 P/FCF- EPS past 5Y-2.51% ROI- 52W High-57.06% Beta-
Dividend %1.11% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low34.96% ATR0.16
Employees97329 Current Ratio- Sales Q/Q-32.60% Oper. Margin- RSI (14)44.61 Volatility4.44% 3.93%
OptionableYes Debt/Eq- EPS Q/Q-42.00% Profit Margin- Rel Volume1.14 Prev Close3.90
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume20.56M Price3.60
Recom1.90 SMA20-2.81% SMA50-3.86% SMA200-17.62% Volume23,385,511 Change-7.69%
Oct-27-20Upgrade Citigroup Neutral → Buy
May-28-20Downgrade Citigroup Buy → Neutral
Apr-06-20Upgrade Goldman Sell → Buy
Jan-21-20Downgrade BofA/Merrill Buy → Neutral
Aug-07-19Upgrade Morgan Stanley Equal-Weight → Overweight
Jun-10-19Initiated Goldman Sell
Jan-22-18Upgrade JP Morgan Neutral → Overweight
Sep-11-17Upgrade Goldman Neutral → Buy
Nov-30-16Resumed Citigroup Buy
Sep-21-16Resumed Goldman Neutral
Apr-27-16Downgrade Barclays Overweight → Equal Weight
Apr-08-16Downgrade Citigroup Neutral → Sell
Mar-14-16Upgrade BofA/Merrill Neutral → Buy
Oct-13-15Downgrade Credit Suisse Neutral → Underperform
Jul-13-15Upgrade Sterne Agee CRT Underperform → Neutral
Apr-22-15Downgrade Goldman Neutral → Sell
Mar-03-09Upgrade UBS Neutral → Buy
Apr-25-08Downgrade Bear Stearns Outperform → Peer Perform
Jun-14-07Upgrade HSBC Securities Neutral → Overweight
Feb-14-07Reiterated HSBC Securities Neutral $50 → $46
Oct-23-20 11:40AM  
Oct-17-20 07:42AM  
Oct-16-20 08:04PM  
Oct-14-20 10:27AM  
Oct-12-20 12:18PM  
Oct-07-20 08:58AM  
Oct-01-20 02:07PM  
Sep-29-20 09:15AM  
Sep-22-20 08:36PM  
10:04AM  
Sep-21-20 02:40PM  
Sep-18-20 11:40AM  
09:21AM  
Sep-17-20 02:15PM  
Sep-15-20 10:04AM  
Sep-14-20 09:01AM  
06:00AM  
Sep-04-20 08:53AM  
Sep-02-20 07:47AM  
Sep-01-20 09:12AM  
Aug-28-20 06:53AM  
Aug-27-20 03:40PM  
Aug-24-20 09:58PM  
02:08PM  
Aug-21-20 02:00AM  
Aug-20-20 01:53PM  
10:38AM  
10:29AM  
Aug-17-20 08:49AM  
Aug-14-20 03:27PM  
Aug-07-20 10:24AM  
09:43AM  
06:00AM  
Aug-06-20 10:32AM  
Jul-31-20 06:02AM  
Jul-30-20 08:13AM  
04:54AM  
Jul-28-20 09:49AM  
Jul-27-20 06:37PM  
11:40AM  
Jul-23-20 06:35AM  
Jul-22-20 12:20PM  
Jul-20-20 01:45PM  
Jul-10-20 11:40AM  
Jun-29-20 07:28AM  
Jun-26-20 12:30PM  
Jun-24-20 11:40AM  
Jun-18-20 05:45PM  
Jun-03-20 07:00AM  
May-26-20 03:51PM  
May-21-20 08:25AM  
May-15-20 05:50PM  
May-06-20 03:36PM  
02:17PM  
May-04-20 09:29PM  
May-01-20 04:52AM  
Apr-30-20 03:11PM  
10:41AM  
05:09AM  
Apr-29-20 06:00AM  
Apr-27-20 12:21PM  
Apr-23-20 07:03PM  
Apr-15-20 04:51PM  
08:48AM  
Apr-13-20 10:32AM  
Apr-08-20 02:51PM  
Apr-06-20 08:55AM  
Apr-02-20 10:44AM  
07:43AM  
Apr-01-20 01:46PM  
Mar-16-20 10:09AM  
Mar-12-20 06:33PM  
Feb-17-20 04:31PM  
Feb-13-20 05:14AM  
Feb-05-20 04:59PM  
10:18AM  
08:12AM  
04:05AM  
Feb-04-20 11:04AM  
Jan-22-20 07:15AM  
Dec-11-19 12:16PM  
Nov-28-19 09:08AM  
08:10AM  
Nov-26-19 09:01AM  
Nov-22-19 06:00AM  
Nov-13-19 04:49PM  
02:23PM  
Oct-31-19 05:58AM  
05:08AM  
Oct-23-19 10:33AM  
Oct-16-19 10:04AM  
08:47AM  
Oct-09-19 04:09PM  
Oct-07-19 04:12PM  
Oct-03-19 06:21PM  
Sep-17-19 09:40AM  
Sep-10-19 05:53PM  
Sep-04-19 05:11PM  
Aug-02-19 09:30AM  
Jul-31-19 04:53PM  
Banco Bradesco S.A., together with its subsidiaries, provides various banking products and financial services to individuals, corporates, and businesses in Brazil and internationally. It operates through two segments, Banking and Insurance. The company offers checking and savings accounts, demand deposits, time deposits, and interbank deposits. It also provides mutual funds, foreign exchange, overdrafts, credit cards, and personal and housing loans; and auto, health, life, accident, and property insurance products. In addition, the company offers fund management and treasury services; corporate finance; investment banking, asset management and consortium administration; pension plans; brokerage; real estate ventures and capitalization bonds; and hedge and finance products, including working capital financing. Banco Bradesco S.A. was founded in 1943 and is headquartered in Osasco, Brazil.
BCEI Bonanza Creek Energy, Inc. daily Stock Chart
BCEI [NYSE]
Bonanza Creek Energy, Inc.
Index- P/E5.07 EPS (ttm)3.52 Insider Own2.20% Shs Outstand20.78M Perf Week-8.55%
Market Cap372.77M Forward P/E5.82 EPS next Y3.07 Insider Trans0.00% Shs Float20.38M Perf Month-8.69%
Income72.70M PEG0.34 EPS next Q0.79 Inst Own- Short Float5.94% Perf Quarter-0.72%
Sales251.40M P/S1.48 EPS this Y-60.30% Inst Trans-0.36% Short Ratio6.87 Perf Half Y2.35%
Book/sh47.08 P/B0.38 EPS next Y-5.28% ROA6.00% Target Price28.00 Perf Year-2.88%
Cash/sh0.20 P/C90.92 EPS next 5Y15.00% ROE7.50% 52W Range8.25 - 25.56 Perf YTD-23.44%
Dividend- P/FCF1.98 EPS past 5Y-41.20% ROI10.40% 52W High-30.09% Beta2.05
Dividend %- Quick Ratio1.60 Sales past 5Y-10.90% Gross Margin84.40% 52W Low116.61% ATR0.98
Employees125 Current Ratio1.70 Sales Q/Q-57.80% Oper. Margin4.00% RSI (14)35.19 Volatility4.81% 4.71%
OptionableYes Debt/Eq0.06 EPS Q/Q-194.30% Profit Margin28.90% Rel Volume0.61 Prev Close19.19
ShortableYes LT Debt/Eq0.06 EarningsNov 05 AMC Payout0.00% Avg Volume175.97K Price17.87
Recom2.00 SMA20-10.02% SMA50-9.35% SMA2003.28% Volume107,802 Change-6.88%
Sep-25-20Initiated Wells Fargo Overweight $33
Jul-27-20Initiated Seaport Global Securities Buy $25
Mar-31-20Upgrade Stifel Hold → Buy $13 → $34
Mar-09-20Downgrade Stifel Buy → Hold $54 → $13
Dec-20-19Resumed Stifel Buy
Sep-04-19Initiated KeyBanc Capital Markets Overweight $26
Jul-24-19Reiterated Imperial Capital Outperform $28 → $30
Mar-01-19Reiterated Imperial Capital Outperform $33 → $35
Dec-14-18Initiated SunTrust Hold
Aug-10-18Reiterated Telsey Advisory Group Outperform $53 → $50
May-10-18Reiterated Imperial Capital Outperform $37 → $48
Apr-26-18Initiated Imperial Capital Outperform $37
Sep-29-16Upgrade Stifel Sell → Hold $0.75 → $1
Aug-02-16Downgrade Wunderlich Hold → Sell $11 → $0
Jul-27-16Downgrade SunTrust Neutral → Reduce
May-25-16Downgrade Imperial Capital In-line → Underperform $3.50 → $1.50
May-10-16Reiterated Imperial Capital In-line $1 → $3.50
May-09-16Downgrade Macquarie Neutral → Underperform
May-06-16Reiterated Topeka Capital Markets Hold $2 → $3
Mar-08-16Downgrade Credit Suisse Outperform → Neutral
Oct-20-20 04:05PM  
Oct-07-20 10:39AM  
Aug-11-20 06:24AM  
Aug-06-20 04:05PM  
01:51PM  
11:13AM  
Aug-05-20 12:14PM  
09:03AM  
08:25AM  
Jul-30-20 03:38PM  
12:33PM  
12:13PM  
Jul-27-20 06:11AM  
Jul-23-20 06:49AM  
Jul-22-20 04:05PM  
Jul-21-20 07:50AM  
Jul-20-20 07:33AM  
Jul-15-20 12:10PM  
Jul-10-20 08:51AM  
Jul-02-20 10:21AM  
Jun-30-20 11:11PM  
Jun-15-20 11:50AM  
Jun-04-20 10:59PM  
May-29-20 11:50AM  
May-21-20 06:27AM  
May-12-20 11:50AM  
06:36AM  
May-09-20 05:31PM  
May-07-20 04:05PM  
Apr-30-20 12:34PM  
06:20AM  
Apr-22-20 04:05PM  
06:34AM  
Apr-08-20 08:34AM  
Mar-31-20 11:21AM  
Mar-27-20 05:09PM  
Mar-24-20 06:41AM  
Mar-23-20 04:10AM  
Mar-13-20 10:49AM  
Mar-12-20 04:36PM  
Mar-10-20 06:40AM  
Mar-05-20 04:23PM  
Feb-27-20 04:05PM  
Feb-13-20 09:52AM  
Feb-11-20 03:55PM  
Feb-04-20 06:07AM  
Jan-28-20 04:05PM  
Jan-06-20 10:20AM  
Dec-31-19 05:27AM  
Dec-30-19 07:58AM  
Dec-21-19 07:56AM  
Dec-19-19 09:04AM  
Dec-10-19 08:02AM  
Dec-02-19 04:05PM  
Nov-29-19 08:16PM  
Nov-20-19 12:55PM  
Nov-15-19 05:46AM  
Nov-06-19 04:32PM  
04:05PM  
Nov-05-19 01:06PM  
Nov-01-19 09:42AM  
Oct-30-19 04:05PM  
Oct-23-19 09:00AM  
Oct-08-19 09:33AM  
Oct-03-19 09:33AM  
07:00AM  
Sep-20-19 04:15PM  
Sep-04-19 12:05PM  
Aug-17-19 11:37PM  
Aug-15-19 01:08PM  
Aug-08-19 01:23PM  
Aug-07-19 04:36PM  
Aug-01-19 07:53AM  
Jul-23-19 10:29AM  
Jul-22-19 04:15PM  
Jun-27-19 01:21PM  
Jun-19-19 07:45AM  
Jun-05-19 07:35AM  
May-29-19 09:31AM  
07:15AM  
May-22-19 12:30PM  
May-21-19 01:33AM  
May-16-19 04:20PM  
10:07AM  
09:23AM  
May-15-19 09:35AM  
08:34AM  
May-14-19 10:06AM  
09:40AM  
May-13-19 10:17AM  
10:07AM  
09:45AM  
May-12-19 09:49PM  
May-10-19 09:02AM  
May-09-19 10:09AM  
May-08-19 07:46PM  
04:45PM  
May-07-19 08:44AM  
May-06-19 10:59AM  
Apr-26-19 06:29PM  
Bonanza Creek Energy, Inc., an exploration and production company, focuses on the extraction of onshore oil and related liquids-rich natural gas in the United States. Its primary oil and liquids-weighted assets are located in the Wattenberg Field in Colorado. As of December 31, 2019, the company had proved reserves of 121.9 million barrel of oil equivalent. Bonanza Creek Energy, Inc. was founded in 1999 and is headquartered in Denver, Colorado.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
DeMuth BrantEVP & Chief Financial OfficerNov 21Buy16.803,00050,40037,283Nov 21 05:55 PM
BMY Bristol-Myers Squibb Company daily Stock Chart
BMY [NYSE]
Bristol-Myers Squibb Company
IndexS&P 500 P/E- EPS (ttm)-0.10 Insider Own0.10% Shs Outstand2.26B Perf Week-3.78%
Market Cap131.55B Forward P/E7.82 EPS next Y7.39 Insider Trans-8.28% Shs Float2.25B Perf Month-3.57%
Income-563.00M PEG- EPS next Q1.49 Inst Own76.30% Short Float0.52% Perf Quarter-1.89%
Sales34.86B P/S3.77 EPS this Y-33.90% Inst Trans0.30% Short Ratio1.18 Perf Half Y-5.02%
Book/sh21.69 P/B2.66 EPS next Y17.84% ROA-0.50% Target Price73.69 Perf Year3.57%
Cash/sh9.51 P/C6.07 EPS next 5Y22.15% ROE-1.30% 52W Range45.76 - 68.34 Perf YTD-10.02%
Dividend1.80 P/FCF15.26 EPS past 5Y10.90% ROI5.50% 52W High-15.48% Beta0.64
Dividend %3.12% Quick Ratio1.40 Sales past 5Y10.50% Gross Margin69.90% 52W Low26.22% ATR1.24
Employees30000 Current Ratio1.50 Sales Q/Q61.50% Oper. Margin15.00% RSI (14)36.02 Volatility1.94% 2.02%
OptionableYes Debt/Eq0.95 EPS Q/Q-104.30% Profit Margin-1.60% Rel Volume1.20 Prev Close58.74
ShortableYes LT Debt/Eq0.85 Earnings- Payout- Avg Volume9.88M Price57.76
Recom1.90 SMA20-4.21% SMA50-4.33% SMA200-4.07% Volume11,899,844 Change-1.67%
Oct-19-20Upgrade Guggenheim Neutral → Buy $70
Sep-29-20Initiated Berenberg Buy $73
Jul-28-20Initiated Raymond James Outperform $75
Apr-02-20Upgrade Morgan Stanley Equal-Weight → Overweight $64
Mar-23-20Downgrade Societe Generale Buy → Hold $50
Feb-27-20Initiated Barclays Equal Weight $69
Jan-06-20Resumed Citigroup Buy $73
Dec-13-19Upgrade Argus Hold → Buy $80
Nov-22-19Resumed Morgan Stanley Equal-Weight $60
Oct-17-19Resumed BofA/Merrill Buy $60
Aug-14-19Upgrade Atlantic Equities Neutral → Overweight $63
May-28-19Initiated Goldman Buy
May-20-19Downgrade Argus Buy → Hold
May-03-19Upgrade Barclays Equal Weight → Overweight $53 → $55
May-03-19Resumed JP Morgan Overweight $62
Jan-15-19Upgrade Societe Generale Sell → Buy
Oct-22-18Downgrade Citigroup Buy → Neutral
Oct-09-18Resumed Guggenheim Neutral
Aug-08-18Upgrade Atlantic Equities Underweight → Neutral
Apr-17-18Downgrade Morgan Stanley Overweight → Equal-Weight
Oct-28-20 04:48PM  
12:47PM  
12:30PM  
Oct-27-20 08:45AM  
07:05AM  
Oct-26-20 05:45PM  
02:47PM  
08:00AM  
05:51AM  
Oct-24-20 07:30AM  
Oct-23-20 10:05AM  
07:45AM  
07:11AM  
Oct-22-20 10:15AM  
Oct-21-20 10:48AM  
Oct-19-20 05:25PM  
05:21PM  
04:27PM  
03:24PM  
12:06PM  
11:55AM  
11:47AM  
09:50AM  
06:59AM  
06:06AM  
Oct-18-20 09:30AM  
Oct-17-20 07:11AM  
Oct-16-20 03:24PM  
07:45AM  
07:12AM  
Oct-10-20 06:06PM  
Oct-09-20 07:46PM  
Oct-08-20 04:13PM  
04:11PM  
11:39AM  
Oct-07-20 04:22PM  
09:33AM  
07:43AM  
07:30AM  
07:19AM  
07:17AM  
06:59AM  
Oct-06-20 03:52PM  
12:10PM  
08:00AM  
Oct-05-20 04:26PM  
02:47PM  
02:35PM  
01:26PM  
12:38PM  
11:41AM  
11:27AM  
11:13AM  
10:45AM  
10:24AM  
09:15AM  
09:11AM  
08:25AM  
08:19AM  
06:49AM  
06:40AM  
06:30AM  
06:29AM  
Oct-03-20 06:36AM  
Oct-02-20 04:17PM  
04:12PM  
02:07PM  
06:59AM  
06:59AM  
Oct-01-20 01:55PM  
Sep-29-20 06:59AM  
Sep-26-20 08:00AM  
Sep-25-20 09:27AM  
05:16AM  
Sep-24-20 04:15PM  
Sep-23-20 01:28PM  
Sep-22-20 04:22PM  
01:20PM  
06:59AM  
Sep-21-20 04:16PM  
12:31PM  
12:30PM  
Sep-20-20 08:09AM  
Sep-19-20 12:30PM  
Sep-18-20 06:05PM  
10:53AM  
07:17AM  
Sep-17-20 04:16PM  
03:50PM  
11:28AM  
06:59AM  
06:15AM  
Sep-15-20 12:27PM  
12:09PM  
07:30AM  
06:59AM  
Sep-14-20 09:48AM  
Sep-12-20 08:30AM  
Sep-11-20 02:39PM  
10:20AM  
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers products in the following therapeutic classes: hematology, oncology, cardiovascular, and immunology. The company's products include Opdivo, a biological product for anti-cancer indications; Eliquis, an oral inhibitor targeted at stroke prevention in adult patients with non-valvular atrial fibrillation, and the prevention and treatment of venous thromboembolic disorders; and Orencia, a biological product for adult patients with active RA and prostate-specific antigen, as well as reducing signs and symptoms in pediatric patients with active polyarticular juvenile idiopathic arthritis. It also provides Sprycel, a tyrosine kinase inhibitor for the treatment of Philadelphia chromosome-positive chronic myeloid leukemia; Yervoy, a monoclonal antibody for the treatment of patients with unresectable or metastatic melanoma; Empliciti, a humanized monoclonal antibody for the treatment of multiple myeloma; and Baraclude, an oral antiviral agent for the treatment of chronic hepatitis B. In addition, it offers Reyataz, a protease inhibitor for the treatment of human immunodeficiency virus (HIV); Sustiva franchise, a non-nucleoside reverse transcriptase inhibitor for the treatment of HIV; and Daklinza NS5A replication complex inhibitor, Sunvepra NS3 protease inhibitor, and Beclabuvir NS5B inhibitor. It sells products to wholesalers, retail pharmacies, hospitals, government entities, and medical profession. The company has collaboration agreements with Pfizer, Otsuka, Ono, Nektar, GRYT Health, and Ubiquigent Limited; clinical collaboration agreement with NeoImmuneTech, Inc.; and partnership with Astrazeneca Plc. The company was formerly known as Bristol-Myers Company and changed its name to Bristol-Myers Squibb Company in 1989. Bristol-Myers Squibb Company was founded in 1887 and is headquartered in New York, New York.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Santiago Karen MurphySVP & ControllerSep 01Option Exercise0.0064208,390Sep 02 04:33 PM
Caforio GiovanniChairman and CEOAug 31Sale62.7039,8402,497,968445,584Sep 02 04:34 PM
Eid JosephSVP,Head Glob. Medical AffairsAug 17Sale64.005,327340,9282,534Aug 19 06:15 PM
LEUNG SANDRAEVP, General CounselAug 13Sale63.24141,4208,943,401432,744Aug 17 04:55 PM
Elkins David VEVP, Chief Financial OfficerAug 01Option Exercise0.0046,402080,698Aug 04 04:43 PM
Hirawat SamitEVP,Chief Med.Offr.,Drug Dev.Jul 01Option Exercise0.009,35609,356Jul 02 04:56 PM
Santiago Karen MurphySVP & ControllerJul 01Option Exercise0.001,06908,115Jul 02 04:54 PM
Paliwal Dinesh CDirectorJun 15Buy54.509,174499,98322,109Jun 16 05:15 PM
BONNEY MICHAEL WDirectorJun 14Option Exercise0.0055808,650Jun 16 05:16 PM
Haller Julia ADirectorJun 14Option Exercise0.0055806,819Jun 16 05:15 PM
Haller Julia ADirectorJun 13Option Exercise0.0090306,261Jun 16 05:15 PM
BONNEY MICHAEL WDirectorJun 13Option Exercise0.0090308,092Jun 16 05:16 PM
Eid JosephSVP,Head Glob. Medical AffairsJun 03Option Exercise0.002,15408,599Jun 09 07:15 PM
Haller Julia ADirectorJun 03Option Exercise0.002,94905,358Jun 05 04:39 PM
BONNEY MICHAEL WDirectorJun 03Option Exercise0.002,94907,189Jun 05 04:40 PM
Dubow AdamSVP,ChiefCompliance&EthicsOff.May 22Sale61.013,200195,23216,086May 26 05:17 PM
Schmukler Louis SEVP,Pres.,Glob.Prod. & SupplyMay 19Sale62.6825,0001,567,00026,777May 21 05:22 PM
VESSEY RUPERTEVP, Research & Early Dev.May 01Option Exercise0.0010,707059,050May 05 04:49 PM
AHMED NADIMEVP and President, HematologyMay 01Option Exercise0.002,908027,463May 05 04:49 PM
Schmukler Louis SEVP,Pres.,Glob.Prod. & SupplyMar 10Option Exercise0.0030,519058,379Mar 12 06:18 PM
von Autenried PaulEVP, Chief Information OfficerMar 10Option Exercise0.0020,8060152,400Mar 12 06:19 PM
Powell AnnEVP, Chief Human ResourcesMar 10Option Exercise0.0031,169058,421Mar 12 06:17 PM
Santiago Karen MurphyControllerMar 10Option Exercise0.005,06307,778Mar 12 06:17 PM
LEUNG SANDRAEVP, General CounselMar 10Option Exercise0.0051,5980588,175Mar 12 06:15 PM
Eid JosephSVP,Head Glob. Medical AffairsMar 10Option Exercise0.001,57106,652Mar 12 06:13 PM
Elicker John EEVP, Investor RelationsMar 10Option Exercise0.0018,407075,102Mar 12 06:14 PM
Caforio GiovanniChairman and CEOMar 10Option Exercise0.00211,7960544,032Mar 12 06:11 PM
Dubow AdamSVP,ChiefCompliance&EthicsOff.Mar 10Option Exercise0.005,007020,091Mar 12 06:12 PM
Bancroft Charles AEVP, Head of IntegrationMar 10Option Exercise0.0071,8680153,637Mar 12 06:11 PM
BOERNER CHRISTOPHER S.EVP, Chief Commercial OfficerMar 10Option Exercise0.0021,426026,091Mar 12 06:11 PM
Elicker John EEVP, Investor RelationsMar 04Sale61.0115,805964,26358,666Mar 06 05:20 PM
VESSEY RUPERTPres., Research & Early Dev.Mar 02Option Exercise51.6993,4684,831,452132,651Mar 04 06:19 PM
VESSEY RUPERTPres., Research & Early Dev.Mar 02Sale60.5984,3085,108,22248,343Mar 04 06:19 PM
AHMED NADIMPresident, HematologyMar 01Option Exercise0.0017,204033,028Mar 03 08:04 PM
Elkins David VEVP, Chief Financial OfficerMar 01Option Exercise0.0024,579044,766Mar 03 08:04 PM
VESSEY RUPERTPres., Research & Early Dev.Mar 01Option Exercise0.0023,349048,106Mar 03 08:05 PM
AHMED NADIMPresident, HematologyFeb 04Option Exercise0.002,076016,895Feb 06 08:48 PM
VESSEY RUPERTPres., Research & Early Dev.Feb 04Option Exercise0.003,592025,920Feb 06 08:49 PM
Elkins David VEVP, Chief Financial OfficerDec 31Option Exercise0.0012,373026,281Jan 03 07:00 PM
VESSEY RUPERTPres., Research & Early Dev.Dec 31Option Exercise0.0016,060030,778Jan 03 07:00 PM
Dubow AdamChief Compliance & Ethics OffiDec 05Sale58.811,740102,32915,749Dec 09 04:44 PM
BONNEY MICHAEL WDirectorDec 04Buy58.90885,1837,189Jun 09 07:16 PM
Eid JosephSVPHead Global Medical AffairsDec 01Option Exercise0.002,82504,995Dec 03 05:28 PM
Schmukler Louis SPres., Global Mfg. & SupplyNov 05Sale56.5625,0001,414,00031,963Nov 06 04:54 PM
Elicker John ESVP, Public Affairs & IRNov 05Sale56.6615,000849,90074,471Nov 06 04:54 PM
BSX Boston Scientific Corporation daily Stock Chart
BSX [NYSE]
Boston Scientific Corporation
IndexS&P 500 P/E- EPS (ttm)-0.09 Insider Own0.10% Shs Outstand1.43B Perf Week-8.29%
Market Cap48.34B Forward P/E20.44 EPS next Y1.67 Insider Trans-13.74% Shs Float1.43B Perf Month-9.77%
Income-122.00M PEG- EPS next Q0.25 Inst Own94.70% Short Float0.91% Perf Quarter-12.51%
Sales10.16B P/S4.76 EPS this Y-63.00% Inst Trans0.90% Short Ratio1.62 Perf Half Y-9.10%
Book/sh11.07 P/B3.08 EPS next Y64.89% ROA13.50% Target Price46.38 Perf Year-18.40%
Cash/sh1.22 P/C28.04 EPS next 5Y8.63% ROE30.00% 52W Range24.10 - 46.62 Perf YTD-24.66%
Dividend- P/FCF53.00 EPS past 5Y46.40% ROI6.00% 52W High-26.92% Beta0.94
Dividend %- Quick Ratio1.40 Sales past 5Y7.80% Gross Margin67.70% 52W Low41.37% ATR1.00
Employees36000 Current Ratio1.90 Sales Q/Q-23.90% Oper. Margin6.60% RSI (14)24.39 Volatility3.14% 2.48%
OptionableYes Debt/Eq0.61 EPS Q/Q-199.20% Profit Margin39.20% Rel Volume2.25 Prev Close36.05
ShortableYes LT Debt/Eq0.59 EarningsOct 28 BMO Payout0.00% Avg Volume7.95M Price34.07
Recom1.70 SMA20-12.17% SMA50-13.46% SMA200-9.52% Volume17,914,798 Change-5.49%
Sep-17-20Initiated Truist Buy $47
Sep-11-20Initiated Wolfe Research Peer Perform $46
Apr-22-20Downgrade SVB Leerink Outperform → Mkt Perform $40
Apr-01-20Upgrade Goldman Neutral → Buy $46 → $38
Mar-05-20Initiated Citigroup Buy $48
Feb-13-20Initiated Goldman Neutral $46
Feb-06-20Resumed BTIG Research Buy $46
Dec-30-19Reiterated Cowen Outperform $47 → $52
Dec-19-19Downgrade Needham Strong Buy → Buy $53
Sep-05-19Resumed JP Morgan Overweight $50
Sep-03-19Resumed Barclays Overweight $48
May-13-19Upgrade Evercore ISI In-line → Outperform
Nov-28-18Initiated UBS Buy
Oct-16-18Initiated Barclays Overweight $43
Oct-02-18Reiterated Morgan Stanley Overweight $38 → $48
Sep-07-18Reiterated Needham Strong Buy $39 → $43
Sep-04-18Upgrade Jefferies Hold → Buy
Jul-06-18Reiterated Needham Strong Buy
Jun-27-18Initiated Bernstein Outperform $38
Apr-26-18Reiterated Needham Strong Buy $35 → $36
Oct-28-20 12:57PM  
11:25AM  
07:55AM  
06:41AM  
06:30AM  
Oct-27-20 11:48AM  
Oct-23-20 08:36AM  
Oct-21-20 12:32PM  
09:18AM  
Oct-20-20 01:06PM  
09:27AM  
08:01AM  
07:40AM  
07:28AM  
Oct-19-20 08:58AM  
08:49AM  
07:46AM  
Oct-15-20 01:05PM  
Oct-14-20 12:34PM  
06:15AM  
Oct-13-20 08:39AM  
08:37AM  
05:42AM  
Oct-12-20 10:11AM  
09:59AM  
08:31AM  
Oct-09-20 07:36AM  
Oct-08-20 03:35PM  
11:30AM  
10:17AM  
Oct-07-20 07:56AM  
Oct-06-20 10:18AM  
09:14AM  
09:12AM  
Oct-01-20 11:57AM  
09:30AM  
Sep-30-20 04:01PM  
Sep-28-20 06:45AM  
Sep-25-20 10:21AM  
Sep-21-20 07:00AM  
Sep-15-20 09:32AM  
Sep-13-20 09:01AM  
Sep-09-20 06:38PM  
Sep-04-20 09:25AM  
Sep-03-20 07:00AM  
Aug-31-20 01:46PM  
Aug-29-20 08:00AM  
Aug-28-20 11:31AM  
Aug-26-20 09:30AM  
Aug-18-20 09:44AM  
Aug-17-20 09:10AM  
Aug-10-20 04:51PM  
Jul-30-20 10:46AM  
Jul-29-20 11:41AM  
10:25AM  
08:36AM  
08:05AM  
07:35AM  
06:54AM  
06:40AM  
Jul-23-20 10:37AM  
Jul-22-20 12:32PM  
07:24AM  
01:44AM  
Jul-21-20 04:24PM  
08:00AM  
Jul-20-20 07:00AM  
Jul-16-20 08:14AM  
Jul-15-20 07:22AM  
04:14AM  
Jul-14-20 04:16PM  
Jul-11-20 07:13AM  
Jul-08-20 01:17PM  
Jul-03-20 08:30AM  
Jun-30-20 09:30AM  
Jun-29-20 06:55AM  
Jun-14-20 06:25AM  
Jun-11-20 10:53AM  
Jun-10-20 09:43AM  
Jun-08-20 06:45AM  
Jun-03-20 08:59AM  
Jun-01-20 06:50AM  
May-29-20 01:13PM  
11:31AM  
May-27-20 07:01PM  
May-26-20 03:07PM  
09:30AM  
06:11AM  
May-21-20 09:52PM  
12:15PM  
03:06AM  
May-20-20 04:19PM  
May-19-20 07:44PM  
04:01PM  
01:16PM  
May-18-20 07:26PM  
05:00PM  
04:19PM  
03:49PM  
May-14-20 06:20PM  
Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, and micro and drainage catheters to treat cancer. The company was founded in 1979 and is headquartered in Marlborough, Massachusetts.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Pierce David AEVP Pres MedSurgOct 01Sale38.562,28287,9942,690Oct 05 04:23 PM
Fitzgerald Joseph MichaelEVP & Pres, Interven CardioSep 11Option Exercise7.1677,640555,902298,688Sep 14 04:04 PM
Fitzgerald Joseph MichaelEVP & Pres, Interven CardioSep 11Sale40.7677,6403,164,653221,048Sep 14 04:04 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventSep 03Sale42.319,139386,671106,483Sep 08 04:10 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventSep 01Option Exercise6.3160,000378,600175,622Sep 02 04:32 PM
Mirviss Jeffrey B.EVP&Pres, Periph InterventSep 01Sale40.9360,0002,456,028115,622Sep 02 04:32 PM
Pierce David AEVP Pres MedSurgSep 01Sale40.702,04483,1914,972Sep 02 04:32 PM
Nanavaty MaulikSVP & Pres, NeuromodulationAug 28Option Exercise17.266,851118,248266,993Aug 31 04:10 PM
Nanavaty MaulikSVP & Pres, NeuromodulationAug 28Sale40.4538,0001,537,165228,993Aug 31 04:10 PM
Sorenson John BradleySVP, Manuf & Sup ChnAug 26Sale39.067,500292,97138,171Aug 27 04:16 PM
Carruthers WendySVP, Human ResourcesAug 26Sale39.1610,200399,401178,973Aug 27 04:17 PM
Eddy Jodi EuerleSVP, Chief Info & Digital Off.Aug 26Sale38.987,750302,12910,299Aug 27 04:17 PM
Ralls-Morrison DesireeSVP, GC and Corp SecretaryAug 20Sale39.001,18246,09811,450Aug 24 04:06 PM
Pierce David AEVP Pres MedSurgAug 03Sale38.692,38592,2767,016Aug 04 04:05 PM
Pierce David AEVP Pres MedSurgJul 22Sale38.002,17082,4609,401Jul 23 04:06 PM
Monson JonathanVP, Corp Controller and CAOJul 01Option Exercise0.00728034,601Jul 09 10:13 AM
Scanlon MeghanSVP,Pres,Urology Pelvic HealthJul 01Option Exercise0.00854012,529Jul 09 10:13 AM
Pierce David AEVP Pres MedSurgJun 03Sale38.001,62461,71211,571Jun 04 04:17 PM
Pierce David AEVP Pres MedSurgJun 01Option Exercise0.002,972016,512Jun 03 04:06 PM
Butcher Arthur CEVP&Pres, Asia PacificJun 01Option Exercise0.001,761030,106Jun 03 04:06 PM
Pierce David AEVP Pres MedSurgJun 01Sale38.001,96974,82213,195Jun 03 04:06 PM
Pierce David AEVP Pres MedSurgMay 08Sale38.002,05778,16613,540May 11 04:45 PM
Scanlon MeghanSVP,Pres,Urology Pelvic HealthMay 01Option Exercise0.002,061012,301May 04 04:20 PM
Pierce David AEVP Pres MedSurgApr 17Sale38.0014,793562,13415,597Apr 20 04:30 PM
Ballinger Kevin J.EVP & Pres, Interven CardioMar 04Sale38.051,79668,33880,085Mar 05 04:10 PM
Ballinger Kevin J.EVP & Pres, Interven CardioMar 03Option Exercise0.003,303083,388Mar 05 04:10 PM
Fitzgerald Joseph MichaelEVP & President, Rhythm MgmtMar 03Option Exercise0.003,6030222,827Mar 05 04:10 PM
Mackey Edward FEVP, OperationsMar 02Option Exercise0.0019,227074,429Mar 03 04:13 PM
Nanavaty MaulikSVP & Pres, NeuromodulationMar 02Option Exercise16.319,623156,951276,354Mar 03 04:15 PM
Nanavaty MaulikSVP & Pres, NeuromodulationMar 02Sale37.4716,763628,183259,591Mar 03 04:15 PM
Pierce David AEVP Pres MedSurgMar 02Sale38.003,485132,43030,390Mar 03 04:15 PM
Ballinger Kevin J.EVP & Pres, Interven CardioMar 02Sale37.2115,783587,22180,085Mar 03 04:09 PM
Mackey Edward FEVP, OperationsFeb 28Option Exercise0.002,444056,311Mar 03 04:13 PM
Mahoney Michael FChairman, President & CEOFeb 28Option Exercise0.0018,33002,227,941Mar 03 04:13 PM
Butcher Arthur CEVP&Pres, Asia PacificFeb 28Option Exercise0.001,527029,039Mar 03 04:12 PM
Carruthers WendySVP, Human ResourcesFeb 28Option Exercise0.001,6290189,912